Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. β
Go to Publication β
Gut (Gut ) Vol: 67 Issue 5 Pages: 872-881 Pub: 2018 May Epub: 2017 Apr 17 Authors Bennet SMP , Böhn L , Störsrud S , Liljebo T , Collin L , Lindfors P , Törnblom H , Öhman L , Simrén M , |
|
|
Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. β
Go to Publication β
Gut (Gut ) Vol: 67 Issue 5 Pages: 872-881 Pub: 2018 May Epub: 2017 Apr 17 Authors Bennet SMP , Böhn L , Störsrud S , Liljebo T , Collin L , Lindfors P , Törnblom H , Öhman L , Simrén M , |
|
|
Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. β
Go to Publication β
BMC gastroenterology (BMC Gastroenterol ) Vol: 21 Issue 1 Pages: 292 Pub: 2021 Jul 14 Epub: 2021 Jul 14 Authors Naseri K , Dabiri H , Rostami-Nejad M , Yadegar A , Houri H , Olfatifar M , Sadeghi A , Saadati S , Ciacci C , Iovino P , Zali MR , |
|
|
Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. β
Go to Publication β
BMC gastroenterology (BMC Gastroenterol ) Vol: 21 Issue 1 Pages: 292 Pub: 2021 Jul 14 Epub: 2021 Jul 14 Authors Naseri K , Dabiri H , Rostami-Nejad M , Yadegar A , Houri H , Olfatifar M , Sadeghi A , Saadati S , Ciacci C , Iovino P , Zali MR , |
|
|
A diet high in FODMAPs as a novel dietary strategy in diabetes? β
Go to Publication β
Clinical nutrition (Edinburgh, Scotland) (Clin Nutr ) Vol: 41 Issue 10 Pages: 2103-2112 Pub: 2022 Oct Epub: 2022 Aug 7 Authors Chu N , Chan JC , Chow E , |
|
|
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. β
Go to Publication β
BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , |
|
|
Irritable bowel syndrome and gut microbiota. β
Go to Publication β
Current opinion in endocrinology, diabetes, and obesity (Curr Opin Endocrinol Diabetes Obes ) Vol: 27 Issue 1 Pages: 28-35 Pub: 2020 Feb Epub: Authors Canakis A , Haroon M , Weber HC , |
|
|
Irritable bowel syndrome and gut microbiota. β
Go to Publication β
Current opinion in endocrinology, diabetes, and obesity (Curr Opin Endocrinol Diabetes Obes ) Vol: 27 Issue 1 Pages: 28-35 Pub: 2020 Feb Epub: Authors Canakis A , Haroon M , Weber HC , |
|
|
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. β
Go to Publication β
Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther ) Vol: 42 Issue 4 Pages: 418-27 Pub: 2015 Aug Epub: 2015 Jun 24 Authors Chumpitazi BP , Cope JL , Hollister EB , Tsai CM , McMeans AR , Luna RA , Versalovic J , Shulman RJ , |
|
|
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. β
Go to Publication β
Gut (Gut ) Vol: 66 Issue 7 Pages: 1241-1251 Pub: 2017 Jul Epub: 2016 Mar 14 Authors McIntosh K , Reed DE , Schneider T , Dang F , Keshteli AH , De Palma G , Madsen K , Bercik P , Vanner S , |
|
|
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. β
Go to Publication β
Gut (Gut ) Vol: 66 Issue 7 Pages: 1241-1251 Pub: 2017 Jul Epub: 2016 Mar 14 Authors McIntosh K , Reed DE , Schneider T , Dang F , Keshteli AH , De Palma G , Madsen K , Bercik P , Vanner S , |
|
|
Nutritional, microbiological and psychosocial implications of the low FODMAP diet. β
Go to Publication β
Journal of gastroenterology and hepatology (J Gastroenterol Hepatol ) Vol: 32 Suppl 1 Issue Pages: 16-19 Pub: 2017 Mar Epub: Authors Staudacher HM , |
|
|
Nutritional, microbiological and psychosocial implications of the low FODMAP diet. β
Go to Publication β
Journal of gastroenterology and hepatology (J Gastroenterol Hepatol ) Vol: 32 Suppl 1 Issue Pages: 16-19 Pub: 2017 Mar Epub: Authors Staudacher HM , |
|
|
Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. β
Go to Publication β
Clinical nutrition (Edinburgh, Scotland) (Clin Nutr ) Vol: 40 Issue 4 Pages: 1861-1870 Pub: 2021 Apr Epub: 2020 Oct 23 Authors Staudacher HM , Scholz M , Lomer MC , Ralph FS , Irving PM , Lindsay JO , Fava F , Tuohy K , Whelan K , |
|
|
Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota. β
Go to Publication β
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 15 Pages: Pub: 2022 Aug 8 Epub: 2022 Aug 8 Authors Bertuccioli A , Cardinali M , Di Pierro F , Zonzini GB , Matera MR , |
|
|
Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota. β
Go to Publication β
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 15 Pages: Pub: 2022 Aug 8 Epub: 2022 Aug 8 Authors Bertuccioli A , Cardinali M , Di Pierro F , Zonzini GB , Matera MR , |
|
|
Alterations in gut microbiota caused by major depressive disorder or a low FODMAP diet and where they overlap. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1303405 Pub: 2023 Epub: 2024 Jan 8 Authors O'Neill S , Minehan M , Knight-Agarwal CR , Pyne DB , |
|
|
Alterations in gut microbiota caused by major depressive disorder or a low FODMAP diet and where they overlap. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1303405 Pub: 2023 Epub: 2024 Jan 8 Authors O'Neill S , Minehan M , Knight-Agarwal CR , Pyne DB , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
